SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ — CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ — CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075

CJ BIO Publishes Clinical Study on BiomeNrich™ POST SZ075, a Postbiotic Ingredient Demonstrating Skin Improvement Benefits

2026/02/26 19:15
4 min read

SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ — CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed journal. The study strengthens the scientific foundation of the ingredient and supports its positioning as a science-based inner beauty solution.

Growing Importance of Scientific Validation in the Inner Beauty Market

The global beauty and personal care market is rapidly shifting toward “Beauty from within” approaches that improve skin condition through internal health support. In particular, the gut-skin axis has emerged as a key biological pathway linking gut microbiota to skin health, driving increased research into probiotic and postbiotic-based ingestible skincare solutions.

At the same time, consumers increasingly seek objective and measurable evidence addressing visible skin concerns such as UV-induced photoaging, barrier impairment, dryness, roughness, and loss of elasticity. As a result, clinically validated biomarkers and instrumental assessments have become critical in substantiating functional ingredient claims.

CJ BIO’s Science-Based Solution: BiomeNrich™ POST SZ075

BiomeNrich™ POST SZ075 is a postbiotic ingredient within CJ BIO’s Condition-Specific biotics solution brand, BiomeNrich™. It is a 100% plant-based postbiotic produced by fermenting rice germ using Latilactobacillus sakei, a strain originally isolated from kimchi. The ingredient is positioned to support Sleep & Skin Health, developed based on the gut–skin axis concept for inner beauty and mental wellness applications.

The newly published study evaluated the ingredient’s mechanisms of action in improving skin health and influencing skin-related biomarkers. Findings demonstrated significant modulation of key markers associated with barrier integrity, hydration, and wrinkle appearance, including reductions in wrinkle severity and transepidermal water loss (TEWL), alongside increases in skin elasticity and dermal density.

Dual-Action Efficacy of BiomeNrich™ POST SZ075 for Skin Health

A clinical study (n=111, 12 weeks, 500 mg/day) published in Food Science and Biotechnology (2025) confirms the dual functionality of BiomeNrich™ POST SZ075 in combating UV-induced wrinkles and enhancing hydration.

I. Skin wrinkle and roughness

Compared to the placebo, the test group showed significant resilience against UV-induced damage:

  • 1,140% improvement in wrinkle parameters around the eyes.
  • 614% increase in skin elasticity.
  • 172% increase in dermal density

II. Skin hydration and Transepidermal Water Loss

The study also demonstrated improvements in hydration-related and barrier-related parameters:

  • 1,872% decrease in Transepidermal Water Loss (TEWL)
  • 497% improvement in skin roughness and 280% reduction in desquamation.
  • 309% increase in skin moisture content.

Detailed research data on BiomeNrich™ POST SZ075 can be found in CJ BIO’s Nutrition Insight article.
https://na2.hubs.ly/H03W1K20 

Differentiation Through Integrated Evidence

CJ BIO established a multi-layered validation framework for BiomeNrich™ POST SZ075, encompassing in vitro, in vivo, and human clinical studies. This stepwise research design enables mechanistic verification alongside measurable clinical outcomes, strengthening scientific credibility. This integrated validation framework enables brand partners to reference both mechanistic insights and clinical findings when developing product concepts.

In addition to the published clinical study on skin health, CJ BIO has also conducted research exploring sleep-related benefits of BiomeNrich™ POST SZ075, supporting its potential relevance across multiple wellness applications. As a postbiotic ingredient, BiomeNrich™ POST SZ075 offers formulation stability advantages compared to live probiotics, which may facilitate broader product development possibilities.

CJ BIO stated, “This study provides scientific evidence that postbiotics can contribute to skin health. CJ BIO will continue expanding its portfolio of science-backed biotics and functional ingredients to deliver differentiated solutions in the inner beauty market.”

About CJ BIO

CJ BIO is the biotechnology business unit of CJ CheilJedang, leveraging over 70 years of fermentation expertise to deliver functional ingredients and solutions for the food, taste, nutrition, and health industries. CJ BIO is committed to providing sustainable, science-validated bio-solutions that enhance quality of life for customers and consumers worldwide.

Contact Information

Media Inquiries:
CJ BIO
Email: cjbio_brand@cj.net 
Website: https://na2.hubs.ly/H03W1JT0 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cj-bio-publishes-clinical-study-on-biomenrich-post-sz075-a-postbiotic-ingredient-demonstrating-skin-improvement-benefits-302698219.html

SOURCE CJ CheilJedang

Market Opportunity
BIO Protocol Logo
BIO Protocol Price(BIO)
$0.02295
$0.02295$0.02295
+2.09%
USD
BIO Protocol (BIO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

XRP Struggles Below $2: Why Is It Not Going Up?

XRP Struggles Below $2: Why Is It Not Going Up?

XRP (CRYPTO: XRP) remains below the $2 mark since mid-January, but rising network activity and institutional inflows are fueling speculation of a potential Q2 rebound
Share
Coinstats2026/02/26 21:51
XRP Volume Rises 212% on Singapore Exchange as Institutional Appetite Grows

XRP Volume Rises 212% on Singapore Exchange as Institutional Appetite Grows

The post XRP Volume Rises 212% on Singapore Exchange as Institutional Appetite Grows appeared on BitcoinEthereumNews.com. Singapore-based crypto exchange Bitrue
Share
BitcoinEthereumNews2026/02/26 22:12
Fed forecasts only one rate cut in 2026, a more conservative outlook than expected

Fed forecasts only one rate cut in 2026, a more conservative outlook than expected

The post Fed forecasts only one rate cut in 2026, a more conservative outlook than expected appeared on BitcoinEthereumNews.com. Federal Reserve Chairman Jerome Powell talks to reporters following the regular Federal Open Market Committee meetings at the Fed on July 30, 2025 in Washington, DC. Chip Somodevilla | Getty Images The Federal Reserve is projecting only one rate cut in 2026, fewer than expected, according to its median projection. The central bank’s so-called dot plot, which shows 19 individual members’ expectations anonymously, indicated a median estimate of 3.4% for the federal funds rate at the end of 2026. That compares to a median estimate of 3.6% for the end of this year following two expected cuts on top of Wednesday’s reduction. A single quarter-point reduction next year is significantly more conservative than current market pricing. Traders are currently pricing in at two to three more rate cuts next year, according to the CME Group’s FedWatch tool, updated shortly after the decision. The gauge uses prices on 30-day fed funds futures contracts to determine market-implied odds for rate moves. Here are the Fed’s latest targets from 19 FOMC members, both voters and nonvoters: Zoom In IconArrows pointing outwards The forecasts, however, showed a large difference of opinion with two voting members seeing as many as four cuts. Three officials penciled in three rate reductions next year. “Next year’s dot plot is a mosaic of different perspectives and is an accurate reflection of a confusing economic outlook, muddied by labor supply shifts, data measurement concerns, and government policy upheaval and uncertainty,” said Seema Shah, chief global strategist at Principal Asset Management. The central bank has two policy meetings left for the year, one in October and one in December. Economic projections from the Fed saw slightly faster economic growth in 2026 than was projected in June, while the outlook for inflation was updated modestly higher for next year. There’s a lot of uncertainty…
Share
BitcoinEthereumNews2025/09/18 02:59